Protagenic Therapeutics, Inc.\new (PTIX) Shareholders’ equity 2017–2026
Protagenic Therapeutics, Inc.\new (PTIX) shareholders’ equity at each fiscal year-end, per SEC filings.
$2.6MFY2026 · since FY2017: $2.5M → $2.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $2.6M | +152.9% |
| FY2025 | -$5.0M | -235.0% |
| FY2024 | $3.7M | -47.0% |
| FY2023 | $6.9M | -30.4% |
| FY2022 | $9.9M | +964.7% |
| FY2021 | -$1.1M | — |
| FY2017 | $2.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice